ESC Premium Access

Validation of quantitative flow reserve and residual quantitative flow reserve to predict fractional flow reserve post stenting from the DOCTORS study population

Congress Presentation

About the speaker

Doctor Julien Adjedj

Institut Arnault Tzanck, Saint Laurent du Var (France)
0 follower

4 more presentations in this session

Prognostic impact of sarcopenia on major adverse cardiovascular outcomes in coronary artery disease patients undergoing successful percutaneous coronary intervention

Speaker: Doctor D. Kang (Seoul, KR)


Percutaneous coronary intervention versus medical therapy for coronary lesions with positive fractional flow reserve (FFR) but preserved coronary flow reserve (CFR). A substudy of the COMPARE-ACUTE

Speaker: Doctor J. Haeck (Leeuwarden, NL)


Diagnostic performance of quantitative flow ratio from coronary angiography versus fractional flow reserve from computed tomography

Speaker: Doctor H. Emori (Wakayama, JP)


Long-term risk stratification of patients undergoing coronary angiography according to the TIMI risk score for secondary prevention

Speaker: Doctor B. Zafrir (Haifa, IL)


Access the full session

Assessment of residual risk after percutaneous coronary intervention

Speakers: Doctor J. Adjedj, Doctor D. Kang, Doctor J. Haeck, Doctor H. Emori, Doctor B. Zafrir

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb